Sale!

MYCEPT S 360

MYCOPHENOLIC ACID 360MG

MRP	:	~~MRP ₹630.00~~
Price	:	₹525.00
You Save	:	₹105.00 (16.67%)

10 tablet(s) in a strip

SKU: 188 Categories: Kidney Speciality Drugs, Nephrology Tags: NEPHROLOGY, NORMAL CHAIN Brand: MANKIND

Mycept-S 360mg Tablet contains Mycophenolate sodium as its active ingredient and belongs to the class of drugs known as inosine monophosphate dehydrogenase (IMPDH) inhibitors. It is primarily used to help prevent organ rejection in patients who have undergone organ transplants such as kidney, heart, or liver transplantation. This medication is typically prescribed in combination with other immunosuppressive agents to enhance its effectiveness in suppressing the immune response that could otherwise attack the transplanted organ.

Due to the significant risk of birth defects and miscarriage, Mycept-S 360mg is strictly contraindicated during pregnancy unless absolutely necessary and prescribed under exceptional circumstances where no safer alternatives exist. Women of childbearing potential must use effective contraception throughout the course of treatment to prevent pregnancy.

Patients on Mycept-S 360 should also avoid receiving live vaccines during therapy, as their immune response may be diminished, reducing the effectiveness of the vaccine and increasing the risk of infection. In addition, individuals taking this medication should not donate blood during treatment and for at least six weeks after discontinuation to ensure that the drug has been sufficiently cleared from the system.

Substitutes for Mycept-S 360mg, such as Myfortic 360mg, may be considered if necessary, under medical guidance. However, the medicine should not be taken by individuals who are allergic to Mycophenolate sodium or any of the other components in the formulation. It is also important to inform your healthcare provider if you have pre-existing liver or heart conditions prior to starting treatment.

Because Mycept-S 360 weakens the immune system, it increases the risk of certain infections and even skin cancers. As a precaution, patients should minimize exposure to direct sunlight and UV rays. Notify your doctor immediately if you experience symptoms such as unexplained bruising, fever, fatigue, dizziness, jaundice (yellowing of the skin or eyes), vision problems, decreased urine output, or seizures.

Since this immunosuppressive drug can impact an infant’s developing immune system, it should not be used during breastfeeding unless absolutely necessary. In such cases, safer alternatives may be explored with your doctor to avoid complications.

Prevent organ transplant rejections

Mycept-S 360mg Tablet exerts its therapeutic effect by targeting and inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH), a crucial catalyst in the de novo synthesis of guanosine nucleotides. These nucleotides are essential for the DNA and RNA synthesis required during cell replication. By disrupting this pathway, Mycept-S 360mg significantly reduces the proliferation of activated T and B lymphocytes—immune cells that play a central role in initiating and sustaining the immune response against transplanted organs.

Because T and B cells rely heavily on this specific pathway for rapid proliferation, especially after transplant surgery, Mycept-S selectively suppresses their activity without broadly impairing other immune cells that can utilize alternate pathways. This selective immunosuppression helps to minimize the risk of organ rejection while reducing some of the broader immunosuppressive side effects seen with less targeted therapies.

In essence, Mycept-S 360mg helps create a more tolerable immune environment for the transplanted organ, thereby promoting graft survival and reducing the risk of rejection without entirely shutting down the body's immune defense.

It is essential to inform your doctor about all the medications you are currently taking or have recently taken, including prescription drugs, over-the-counter medicines, vaccinations, nutritional or vitamin supplements, and any herbal or alternative remedies. This is because Mycept-S 360mg Tablet has the potential to interact with a variety of other substances, which could either reduce its effectiveness or increase the risk of adverse effects. Certain medications may interfere with how Mycept-S is absorbed, metabolized, or eliminated from the body, leading to either subtherapeutic levels or toxic accumulation. Providing your doctor with a complete list of your medications enables them to identify potential interactions early, adjust dosages if necessary, and ensure that your treatment regimen is both safe and effective.

Mycept-S 360mg Tablet is an oral prescription medication that should be taken strictly under the guidance of your healthcare provider. The dosage and duration of treatment are tailored to your individual condition, the severity of your illness, and how you respond to the medication. It’s crucial to follow your doctor’s instructions carefully—never modify the dose or stop the treatment without consulting them first.

Swallow the tablet whole without opening, crushing, breaking, or chewing it, as altering the form can affect how the drug is absorbed in the body. To maintain consistent blood levels of the medication, take it at the same time each day, as recommended by your physician. This routine helps optimize the medicine’s effectiveness and supports better treatment outcomes.

Store Mycept S 360mg tablet at room temperature between (15°C to 30°C)
Keep the medicine away from the reach of children and pets

Serious

Infections, fever, or sore throat
Unusual bleeding or bruising
Low blood cell count
Severe allergic reactions

Common

Higher risk of developing lymphoma and other cancers
Nausea, abdominal pain
Diarrhea
Constipation
Loss of appetite
Shortness of breath
Weight loss
Increased heartbeat
Headache
Blood pressure problem
Anaemia

Breast Feeding

Unsafe

Mycept S 360mg tablet is not recommended for breastfeeding mothers because small amounts of the drug can pass into the mother's milk and affect the nursing baby.

Alcohol

Unsafe

It is unsafe to consume alcohol when taking Mycept S 360mg tablet because it may cause excessive drowsiness or liver problems.

Liver

Consult Your Doctor

Mycept S 360mg tablet should be cautiously administered in patients with lung diseases. Dose adjustments are necessary. Inform your physician if you have lung problems before initiating the therapy.

Lungs

Unsafe

It is generally considered safe for individuals with liver disease; however, inform your physician if you have any liver diseases.

Driving

Unsafe

Driving vehicles or operating machinery while taking Mycept S 360mg tablet is unsafe because it may cause drowsiness and vision problems.

Pregnancy

Unsafe

Mycept S 360mg tablet is known to have harmful effects on the developing fetus and is generally not taken during pregnancy unless your doctor prescribes the medicine.